News
FINANCIAL POST | Canada, U.S. in NAFTA 'stalemate' over American demands to boost protection for brand-name drugs: industry
“Going up to 10 years of protection for biologics represents a cost to Canadians without any countering benefit,” said Richard Gold, a McGill University law professor. “Canada may have no choice in the current trade climate, but there should be no mistake that to accede to U.S. requests comes at a cost.”